KEY vs NTLA · P/E 13, rev $7.51B vs rev $57.9M
KeyCorp (KEY) versus Intellia Therapeutics Inc (NTLA) — a side-by-side from cached financials, not a winner call.
KeyCorp (KEY) is a banks - regional company listed on US.
Intellia Therapeutics Inc (NTLA) is a biotechnology company listed on US.
Latest reported KEY revenue for 2025-12-31 was $7.51B. Net income was $1.83B. Revenue was up 62.7% from 2024-12-31 to 2025-12-31. KEY currently screens at market cap $22.64B and trailing P/E 12.8.
Latest reported NTLA revenue for 2024-12-31 was $57.9M. Net income was -$519.0M. Revenue was up 59.6% from 2023-12-31 to 2024-12-31. NTLA currently screens at market cap $1.19B.
KEY currently screens at market cap $22.64B and trailing P/E 12.8. NTLA currently screens at market cap $1.19B.
Not investment advice. Open the KEY and NTLA stock pages for the full models.
Not investment advice.